HF Advisory Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1963169 Annapolis, MD

Position in GILD

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$2,964,315

+$48,834 QoQ

Shares Held

23,463

+12.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.34%

of 13F equity value

Holder Rank

#716

of 2,266 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HF Advisory Group, LLC holds $13,388,647 across 8 Drug Manufacturers - General names. GILD ranks #1 (22.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	23,463	$2,964,315
2	LLY	ELI LILLY & Co	2,246	$2,693,920
3	PFE	Pfizer Inc	102,378	$2,465,262
4	SNY	Sanofi	37,289	$1,590,748
5	NVS	Novartis AG	8,551	$1,340,112
6	JNJ	Johnson & Johnson	4,322	$1,097,658
7	AMGN	Amgen Inc	2,318	$839,394
8	GSK	GSK plc	7,578	$397,238

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,964,315	23,463	+12.2%	Shares	Sole	2026-07-09
2026-03-31	$2,915,481	20,919	+1.7%	Shares	Sole	2026-04-21
2025-12-31	$2,525,498	20,576	+3.6%	Shares	Sole	2026-01-23
2025-09-30	$2,204,904	19,864	+7.3%	Shares	Sole	2025-10-06
2025-06-30	$2,053,312	18,520	+9.3%	Shares	Sole	2025-07-10
2025-03-31	$1,898,127	16,940	+4.7%	Shares	Sole	2025-04-10
2024-12-31	$1,494,177	16,176	-9.7%	Shares	Sole	2025-01-15
2024-09-30	$1,501,825	17,913	-1.5%	Shares	Sole	2024-10-30
2024-06-30	$1,248,015	18,190	+17.6%	Shares	Sole	2024-07-18
2024-03-31	$1,132,884	15,466	+4.3%	Shares	Sole	2024-04-22
2023-12-31	$1,201,135	14,827	+2.1%	Shares	Sole	2024-01-31
2023-09-30	$1,088,053	14,519	+13.9%	Shares	Sole	2023-10-31
2023-06-30	$982,642	12,750	+21.1%	Shares	Sole	2023-07-20
2023-03-31	$873,757	10,531	+18.3%	Shares	Sole	2023-04-19
2022-12-31	$764,494	8,905	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.